Status:
RECRUITING
68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
The Leona M. and Harry B. Helmsley Charitable Trust
Conditions:
Crohn's Disease
Intestinal Fibrosis
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This study is a prospective, case-control study evaluating whether the PET radiotracer 68Ga-FAPI-46 can detect fibrostenosing Crohn's disease in the small bowel. The goal is to determine whether areas...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
January 26 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2027
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT07273188
Start Date
January 26 2026
End Date
April 30 2027
Last Update
February 9 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905